Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, New York.
Montrose Technology, Inc, North Andover, Massachusetts.
Int J Radiat Oncol Biol Phys. 2014 Mar 1;88(3):746-52. doi: 10.1016/j.ijrobp.2013.11.006. Epub 2014 Jan 7.
A novel (32)P brachytherapy source has been in use at our institution intraoperatively for temporary radiation therapy of the spinal dura and other localized tumors. We describe the dosimetry and clinical implementation of the source.
Dosimetric evaluation for the source was done with a complete set of MCNP5 Monte Carlo calculations preceding clinical implementation. In addition, the depth dose curve and dose rate were measured by use of an electron field diode to verify the Monte Carlo calculations. Calibration procedures using the diode in a custom-designed phantom to provide an absolute dose calibration and to check dose uniformity across the source area for each source before treatment were established.
Good agreement was established between the Monte Carlo calculations and diode measurements. Quality assurance measurements results are provided for about 100 sources used to date. Clinical source calibrations were usually within 10% of manufacturer specifications. Procedures for safe handling of the source are described.
Clinical considerations for using the source are discussed.
我们机构一直在手术中使用一种新型(32)P 近距离放射治疗源,对硬脊膜和其他局部肿瘤进行临时放射治疗。我们描述了该源的剂量学和临床实施情况。
在临床实施之前,使用一套完整的 MCNP5 蒙特卡罗计算对该源进行了剂量学评估。此外,使用电子束场二极管测量了深度剂量曲线和剂量率,以验证蒙特卡罗计算。建立了使用定制设计的体模中的二极管进行校准程序,以便在治疗前为每个源提供绝对剂量校准,并检查源区域内的剂量均匀性。
蒙特卡罗计算和二极管测量之间建立了良好的一致性。提供了约 100 个迄今为止使用的源的质量保证测量结果。临床源校准通常在制造商规格的 10%以内。描述了安全处理源的程序。
讨论了使用该源的临床注意事项。